- Home
- AUST vs PMN Comparison
AUST vs PMN Comparison
Compare AUST & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AUST | PMN |
|---|---|---|
| Founded | 2020 | 2004 |
| Country | Canada | Canada |
| Employees | N/A | N/A |
| Industry | | Pharmaceuticals and Biotechnology |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.2M | 23.5M |
| IPO Year | 2022 | N/A |
Fundamental Metrics
Financial Performance| Metric | AUST | PMN |
|---|---|---|
| Price | $2.20 | $11.05 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $72.67 |
| AVG Volume (30 Days) | ★ 2.9M | 16.9K |
| Earning Date | 02-26-2026 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.05 | $6.27 |
| 52 Week High | $3.92 | $39.75 |
Technical Indicators
Market Signals| Indicator | AUST | PMN |
|---|---|---|
| Relative Strength Index (RSI) | 67.30 | 74.00 |
| Support Level | $1.71 | $8.96 |
| Resistance Level | $3.92 | $10.18 |
| Average True Range (ATR) | 0.34 | 0.65 |
| MACD | 0.06 | 0.12 |
| Stochastic Oscillator | 26.60 | 85.03 |
Price Performance
Historical ComparisonAbout AUST Austin Gold Corp.
Austin Gold Corp is focused on the acquisition, exploration and evaluation of mineral resource properties in the western United States of America (USA). Exploration and development of mineral projects is considered the Company's single business segment. Its projects include Kelly Creek in Humboldt County, Lone Mountain and Miller in Elko County, and Stockade Mountain (Oregon).
About PMN ProMIS Neurosciences Inc. (ON)
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.